StocksMedium•29 September 2026•
1 min read
Bayer Faces New Missouri Trial Over Roundup Weedkiller Safety Claims
Key Facts
1A trial began in Missouri where Bayer's Monsanto unit is accused of failing to adequately test Roundup weedkiller before selling it.
2The trial follows a recent Bayer win at the US Supreme Court, serving as a test for the viability of remaining Roundup litigation.
A trial began in Missouri where Bayer's Monsanto unit is accused of failing to adequately test Roundup weedkiller before selling it. Reuters reported that the case involves three cancer patients who claim the company failed to warn about or properly test the safety of the product.
The trial follows a recent Bayer win at the US Supreme Court, serving as a test for the viability of remaining Roundup litigation. BAYRY closed at $14.46 on September 28, 2026, as the company seeks to limit its liability across thousands of remaining lawsuits.